Vaxtex Historical Income Statement

VCL Stock

0.87 0.01 1.16%

Historical analysis of Vaxtex Cotfab income statement accounts such as Depreciation And Amortization of 1.5 M, Total Revenue of 309.9 M, Other Operating Expenses of 309.7 M or Cost Of Revenue of 277.3 M can show how well Vaxtex Cotfab Limited performed in making a profits. Evaluating Vaxtex Cotfab income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Vaxtex Cotfab's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Vaxtex Cotfab Limited latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vaxtex Cotfab Limited is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxtex Cotfab Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Vaxtex Income Statement Analysis

Vaxtex Cotfab Limited Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Vaxtex Cotfab shareholders. The income statement also shows Vaxtex investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Vaxtex Cotfab Income Statement Chart

At present, Vaxtex Cotfab's Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 277.3 M, whereas Gross Profit is projected to grow to (44.8 M).

Total Revenue Other Operating Expenses Cost Of Revenue Income Tax Expense

Total Revenue

Total revenue comprises all receipts Vaxtex Cotfab Limited generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Vaxtex Cotfab Limited. It is also known as Vaxtex Cotfab overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Vaxtex Cotfab Limited income statement and represents the costs associated with goods and services Vaxtex Cotfab provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Vaxtex Cotfab's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Vaxtex Cotfab Limited current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxtex Cotfab Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Total Revenue	756.2M	166.2M	191.1M	309.9M
Depreciation And Amortization	2.8M	1.5M	1.8M	1.5M

Total Revenue Depreciation And Amortization

Vaxtex Cotfab income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		0.95	0.32	0.96	-0.06	-0.12	-0.1	0.96	0.25	-0.15	-0.89	-0.18	0.69	0.67	0.64	0.14	0.32	0.54	0.8	-0.19	0.84
Total Revenue	0.95		0.48	0.99	0.13	0.08	0.1	0.99	0.45	0.08	-0.75	0.06	0.58	0.67	0.74	0.07	0.34	0.36	0.67	0.04	0.89
Gross Profit	0.32	0.48		0.41	0.85	0.82	0.83	0.36	0.98	0.82	0.06	0.8	0.41	0.48	0.15	0.16	0.59	-0.57	-0.18	0.78	0.29
Other Operating Expenses	0.96	0.99	0.41		0.04	-0.01	0.02	1.0	0.38	-0.01	-0.79	-0.03	0.57	0.64	0.75	0.09	0.28	0.43	0.73	-0.04	0.88
Operating Income	-0.06	0.13	0.85	0.04		1.0	1.0	0.01	0.83	0.97	0.32	0.97	0.11	0.46	-0.03	-0.17	0.62	-0.85	-0.5	0.97	0.04
Ebit	-0.12	0.08	0.82	-0.01	1.0		1.0	-0.04	0.82	0.99	0.39	0.99	0.03	0.4	-0.05	-0.2	0.57	-0.89	-0.54	0.98	0.0
Ebitda	-0.1	0.1	0.83	0.02	1.0	1.0		-0.01	0.82	0.99	0.37	0.98	0.05	0.41	-0.03	-0.2	0.58	-0.87	-0.52	0.98	0.02
Cost Of Revenue	0.96	0.99	0.36	1.0	0.01	-0.04	-0.01		0.33	-0.04	-0.81	-0.06	0.54	0.65	0.76	0.04	0.27	0.46	0.76	-0.07	0.89
Total Operating Expenses	0.25	0.45	0.98	0.38	0.83	0.82	0.82	0.33		0.84	0.16	0.83	0.28	0.38	0.19	0.15	0.47	-0.6	-0.22	0.81	0.25
Income Before Tax	-0.15	0.08	0.82	-0.01	0.97	0.99	0.99	-0.04	0.84		0.44	1.0	-0.04	0.31	-0.02	-0.2	0.51	-0.89	-0.54	1.0	0.0
Total Other Income Expense Net	-0.89	-0.75	0.06	-0.79	0.32	0.39	0.37	-0.81	0.16	0.44		0.46	-0.61	-0.59	-0.54	-0.03	-0.23	-0.74	-0.87	0.46	-0.75
Net Income	-0.18	0.06	0.8	-0.03	0.97	0.99	0.98	-0.06	0.83	1.0	0.46		-0.08	0.3	-0.02	-0.21	0.48	-0.9	-0.56	1.0	-0.02
Income Tax Expense	0.69	0.58	0.41	0.57	0.11	0.03	0.05	0.54	0.28	-0.04	-0.61	-0.08		0.44	-0.05	0.41	0.7	0.32	0.52	-0.1	0.59
Interest Expense	0.67	0.67	0.48	0.64	0.46	0.4	0.41	0.65	0.38	0.31	-0.59	0.3	0.44		0.57	-0.17	0.49	-0.06	0.25	0.3	0.5
Selling General Administrative	0.64	0.74	0.15	0.75	-0.03	-0.05	-0.03	0.76	0.19	-0.02	-0.54	-0.02	-0.05	0.57		-0.08	-0.25	0.27	0.42	-0.02	0.51
Selling And Marketing Expenses	0.14	0.07	0.16	0.09	-0.17	-0.2	-0.2	0.04	0.15	-0.2	-0.03	-0.21	0.41	-0.17	-0.08		-0.15	0.18	0.09	-0.25	-0.11
Tax Provision	0.32	0.34	0.59	0.28	0.62	0.57	0.58	0.27	0.47	0.51	-0.23	0.48	0.7	0.49	-0.25	-0.15		-0.25	0.12	0.48	0.48
Net Interest Income	0.54	0.36	-0.57	0.43	-0.85	-0.89	-0.87	0.46	-0.6	-0.89	-0.74	-0.9	0.32	-0.06	0.27	0.18	-0.25		0.85	-0.9	0.45
Interest Income	0.8	0.67	-0.18	0.73	-0.5	-0.54	-0.52	0.76	-0.22	-0.54	-0.87	-0.56	0.52	0.25	0.42	0.09	0.12	0.85		-0.56	0.74
Net Income From Continuing Ops	-0.19	0.04	0.78	-0.04	0.97	0.98	0.98	-0.07	0.81	1.0	0.46	1.0	-0.1	0.3	-0.02	-0.25	0.48	-0.9	-0.56		-0.02
Reconciled Depreciation	0.84	0.89	0.29	0.88	0.04	0.0	0.02	0.89	0.25	0.0	-0.75	-0.02	0.59	0.5	0.51	-0.11	0.48	0.45	0.74	-0.02

Click cells to compare fundamentals

Vaxtex Cotfab Account Relationship Matchups

Vaxtex Cotfab income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	1.5M	3.0M	2.8M	1.5M	1.8M	1.5M
Total Revenue	261.5M	619.1M	756.2M	166.2M	191.1M	309.9M
Gross Profit	26.9M	77.8M	53.1M	(52.4M)	(47.2M)	(44.8M)
Other Operating Expenses	248.7M	592.0M	762.8M	221.2M	254.4M	309.7M
Operating Income	12.9M	27.1M	1.1M	(54.7M)	(49.2M)	(46.7M)
Ebit	12.9M	30.9M	1.1M	(87.7M)	(78.9M)	(75.0M)
Ebitda	14.4M	33.9M	3.9M	(86.2M)	(77.5M)	(73.7M)
Cost Of Revenue	234.6M	541.3M	703.2M	218.7M	251.4M	277.3M
Total Operating Expenses	14.1M	50.6M	59.7M	(52.4M)	(47.2M)	(44.8M)
Income Before Tax	2.6M	20.1M	11.6M	(88.3M)	(79.5M)	(75.5M)
Total Other Income Expense Net	(29.0M)	(43.6M)	(30.0M)	(33.7M)	(30.3M)	(28.8M)
Net Income	1.8M	14.9M	11.3M	(88.3M)	(79.5M)	(75.5M)
Income Tax Expense	843.2K	5.2M	269K	1.4M	1.6M	1.5M
Interest Expense	10.7M	10.6M	6.3M	658K	756.7K	718.9K
Selling General Administrative	6.5M	729.1K	13.0M	2.1M	2.4M	3.9M
Selling And Marketing Expenses	37K	75.8K	61K	447K	402.3K	228.6K
Net Interest Income	(10.5M)	(7.0M)	(6.3M)	(658K)	(756.7K)	(794.5K)
Net Income From Continuing Ops	1.8M	14.9M	11.3M	(88.3M)	(79.5M)	(75.5M)
Reconciled Depreciation	1.5M	3.0M	2.8M	1.5M	1.8M	2.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
C	Citigroup

Other Information on Investing in Vaxtex Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vaxtex Historical Income Statement

About Vaxtex Income Statement Analysis

Vaxtex Cotfab Income Statement Chart

Total Revenue

Other Operating Expenses

Cost Of Revenue

Vaxtex Cotfab income statement Correlations

Vaxtex Cotfab Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vaxtex Cotfab income statement Accounts

Also Currently Popular

Other Information on Investing in Vaxtex Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax
Net Income From Continuing Ops	+ 1.0	Income Before Tax

Net Income From Continuing Ops	- 0.9	Net Interest Income
Net Interest Income	- 0.9	Net Income
Net Interest Income	- 0.89	Income Before Tax
Net Interest Income	- 0.89	Ebit
Total Other Income Expense Net	- 0.89	Depreciation And Amortization
Interest Income	- 0.87	Total Other Income Expense Net